Cantor Fitzgerald Sticks to Its Buy Rating for PureCycle Technologies (PCT)
In a report released today, Andres Sheppard from Cantor Fitzgerald maintained a Buy rating on PureCycle Technologies (PCT – Research Report), with a price target of $16.00. The company's shares closed today at $13.11.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Sheppard is a 4-star analyst with an average return of 11.8% and a 50.00% success rate. Sheppard covers the Consumer Cyclical sector, focusing on stocks such as Tesla, Lucid Group, and Rivian Automotive.
In addition to Cantor Fitzgerald, PureCycle Technologies also received a Buy from Alembic Global's Hassan Ahmed in a report issued on June 17. However, on June 18, Craig-Hallum maintained a Hold rating on PureCycle Technologies (NASDAQ: PCT).
Based on PureCycle Technologies' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.58 million and a net profit of $8.83 million. In comparison, last year the company earned a revenue of $11.94 million and had a GAAP net loss of $85.61 million
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
KANZHUN LIMITED Announces Launch of Share Offer
BEIJING, June 24, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ('BOSS Zhipin' or the 'Company') (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced the launch of its share offer of 30,000,000 Class A ordinary shares, comprising a Hong Kong public offering of initially 3,000,000 Class A ordinary shares (the 'Hong Kong Public Offering') and an international offering of initially 27,000,000 Class A ordinary shares (the 'International Offering', together with the Hong Kong Public Offering, the 'Share Offer'), subject to reallocation and offer size adjustment. The initial offer shares available for the Hong Kong Public Offering and the International Offering are subject to reallocation (including clawback). Additionally, the Company has an offer size adjustment option to increase the number of offer shares based on market demand up to an aggregate of 4,500,000 additional Class A ordinary shares, representing 15% of the initial offer shares. The offer size adjustment option may be exercised on or before the Price Determination Date (defined below). The offer price for the Hong Kong Public Offering (the 'Hong Kong Offer Price') will be no more than HK$78.00 per Class A ordinary share (the 'maximum Hong Kong Offer Price'). The offer price for the International Offering of the Share Offer (the 'International Offer Price') may be set higher than, or the same as, the maximum Hong Kong Offer Price. The Company will set the International Offer Price on or before July 2, 2025, Hong Kong time (the 'Price Determination Date'), by taking into consideration, among other factors, the closing price of the ADSs on Nasdaq on the last trading day on or before the Price Determination Date. The final Hong Kong Offer Price will also be set on the Price Determination Date at the lower of the final International Offer Price and the maximum Hong Kong Offer Price. The Share Offer is intended to further enhance the Company's financial flexibility, broaden its shareholder base, improve stock liquidity, and support its healthy and sustainable development. The net proceeds from the Share Offer will be used in investment in technology and related infrastructure, the development of new business initiatives, strategic acquisitions or investment opportunities and for working capital and general corporate purposes. Goldman Sachs (Asia) L.L.C. and Morgan Stanley Asia Limited (in alphabetical order) act as the overall coordinators for the Share Offer. Goldman Sachs (Asia) L.L.C., Morgan Stanley Asia Limited (in alphabetical order) and Huatai Financial Holdings (Hong Kong) Limited act as the joint global coordinators for the Share Offer. Goldman Sachs (Asia) L.L.C., Morgan Stanley Asia Limited (in alphabetical order), Huatai Financial Holdings (Hong Kong) Limited, Futu Securities International (Hong Kong) Limited and Tiger Brokers (HK) Global Limited act as joint bookrunners and joint lead managers for the Share Offer. The International Offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus included in an automatic shelf registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission (the 'SEC') on December 16, 2022, which automatically became effective upon filing. The registration statement on Form F-3 and the preliminary prospectus supplement are available at the SEC website at: The Share Offer is subject to market and other conditions, and there can be no assurance as to whether or when the Share Offer may be completed, or as to the actual size or terms of the Share Offer. This press release shall not constitute an offer to sell or the solicitation of an offer or an invitation to buy any securities of the Company, nor shall there be any offer or sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. This press release does not constitute a prospectus (including as defined under the laws of Hong Kong) and potential investors should read the prospectus of the Company for detailed information about the Company and the proposed Share Offer, before deciding whether or not to invest in the Company. This press release has not been reviewed or approved by the SEC, the Hong Kong Stock Exchange or the Securities and Futures Commission of Hong Kong. Safe Harbor Statement This press release contains statements that may constitute 'forward-looking' statements which are made pursuant to the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'will,' 'expects,' 'anticipates,' 'aims,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'likely to,' and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in announcements made on the website of The Stock Exchange of Hong Kong Limited, in its interim and annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission and The Stock Exchange of Hong Kong Limited. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law. About KANZHUN LIMITED KANZHUN LIMITED operates the leading online recruitment platform BOSS Zhipin in China. The Company connects job seekers and enterprise users in an efficient and seamless manner through its highly interactive mobile app, a transformative product that promotes two-way communication, focuses on intelligent recommendations, and creates new scenarios in the online recruiting process. Benefiting from its large and diverse user base, BOSS Zhipin has developed powerful network effects to deliver higher recruitment efficiency and drive rapid expansion. For more information, please visit For investor and media inquiries, please contact: KANZHUN LIMITEDInvestor RelationsEmail: ir@ In China： PIACENTE FINANCIAL COMMUNICATIONSHelen WuTel: +86-10-6508-0677Email: kanzhun@ In the United States: PIACENTE FINANCIAL COMMUNICATIONSBrandi PiacentePhone: +1-212-481-2050Email: kanzhun@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
44 minutes ago
- Business Wire
AstroNova Letter to Shareholders Highlights Board's Commitment to Shareholder Value
WEST WARWICK, R.I.--(BUSINESS WIRE)-- AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in data visualization technology, has published a letter to shareholders outlining shared concerns with Samir Patel and actions that have already been taken to address these issues. Additional information regarding the Company and its progress can be found in the investor presentation that was filed with the U.S. Securities and Exchange Commission ('SEC') in connection with its upcoming Annual Meeting of Shareholders scheduled to be held on Wednesday, July 9, 2025. The presentation can be found at the Company's website: Dear Fellow Shareholders, I am Richard S. Warzala, Lead Independent Director of AstroNova. I write to you today to assure you that your Board of Directors shares many of Samir's concerns. This Board has directed a number of actions that are already making AstroNova better. Importantly, as a governing body, the Board has an obligation to all of its shareholders to act in their best interests. This often means undertaking actions which, for the benefit of the Company and its shareholders, are not aired in public. We all agree that the MTEX acquisition, which has meaningful strategic value, did not go as planned despite a due diligence process that included the engagement of accountants, legal counsel and other professionals in Europe and, specifically, Portugal and the U.S. Acquisitions don't always go as planned and when that happens, the key to success is developing a corrective action plan to recover as quickly as possible. In addition to completely restructuring the acquisition, we enhanced the operation with key local resources and leveraged the very capable AstroNova team to drive change almost immediately following the closing. Further actions taken by the Board and management to improve value included: We measurably enhanced our accounting and finance department with the addition of our new CFO in June 2024. We found Tom DeByle through a search that was started in the fall of 2023. We have greatly strengthened the leadership in our Product Identification segment. Jorik Ittmann joined us in September last year as a result of a search that had begun earlier in 2024. He has excellent experience in growing print manufacturing businesses, and we are excited about the many changes he has already made in that segment. We also realigned the operating structure of AstroNova for improved autonomy and ownership for each segment. This change has already been demonstrated with a greater sense of urgency to execute change through improved decision making at the segment level. We recently restructured the compensation program to drive greater focus by the leadership on working capital management, cash generation and earnings per share in addition to revenue growth. We also have been disappointed in the decline in shareholder value, especially since the acquisition, but believe the Company is on track to return share value to levels seen prior to the pandemic when we had realized returns of nearly 90% over 5 years. We also believe that a reasonable settlement is best for our shareholders and are quite open to a collaborative and amicable approach. We engaged with Samir for this exact purpose, but despite discussions, Samir was not open to collaboration as he indicated he would be. This is a serious disappointment. We welcome having conversations with any shareholder and appreciate your investment and patience. With kind regards, We ask Shareholders to Vote 'FOR' AstroNova's six highly qualified director nominees on the WHITE universal proxy card TODAY We, the Board of Directors of AstroNova, Inc. (the 'Company' or 'AstroNova'), urge shareholders to protect their investment by voting the WHITE proxy card for only AstroNova's six nominees and not the Samir Patel and Askeladden Capital Management LLC ('Askeladden') nominees. The 2025 Annual Meeting of Shareholders of AstroNova will be held at the offices of Foley Hoag LLP, Seaport West, 155 Seaport Boulevard, Boston, Massachusetts on Wednesday, July 9, 2025, and all shareholders of record as of the close of business on May 15, 2025, are entitled to vote at the meeting. Shareholders with any questions about how to vote their shares may call the Company's proxy solicitor, Alliance Advisors, toll-free at 1-844-202-6164. About AstroNova AstroNova (Nasdaq: ALOT), a global leader in data visualization technologies since 1969, designs, manufactures, distributes and services a broad range of products that acquire, store, analyze, and present data in multiple formats. Its strategy is to drive profitable growth through innovative new technologies, building its installed base to expand recurring revenue while strategically sourcing its replacement products. The Product Identification segment provides a wide array of digital, end-to-end product marking and identification solutions, including hardware, software, and supplies for OEMs, commercial printers, and brand owners. The Aerospace segment provides products designed for airborne printing solutions, avionics, and data acquisition. Aerospace products include flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. Data acquisition systems are used in research and development, flight testing, missile and rocket telemetry, production monitoring, power, and maintenance applications. For more information please visit: Forward-Looking Statements Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect AstroNova's current expectations concerning future events and results. These statements may include the use of the words 'believes,' 'expects,' 'intends,' 'plans,' 'anticipates,' 'likely,' 'continues,' 'may,' 'will,' and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning AstroNova's anticipated performance, involve risks, uncertainties and other factors, some of which are beyond AstroNova's control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to (i) the risk that our recent leadership changes and enhancements to our incentive compensation programs will not lead to the improved results we expect; and (ii) those factors set forth in AstroNova's Annual Report on Form 10-K for the fiscal year ended January 31, 2025 and subsequent filings AstroNova makes with the Securities and Exchange Commission. AstroNova undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release. Important Additional Information In connection with its 2025 Annual Meeting of Shareholders, AstroNova has filed a definitive proxy statement with the SEC and caused it to be mailed, together with an annual report and proxy card, to each of our shareholders. The proxy statement and a copy of the other materials that we file with the SEC from time to time, including our Annual Report on Form 10-K, as amended, for the fiscal year ended January 31, 2025, may be obtained free of charge via the Internet at and through the Investor Relations page of our corporate website, In addition, investors and security holders may obtain free copies of the proxy statement, the annual report and other proxy materials by directing a written request to ALOTproxy@ The proxy statement and other relevant materials we have made or will make available contain important information about the director nominees and the other matters to be voted upon by shareholders at the 2025 Annual Meeting of Shareholders. AstroNova urges shareholders to read the proxy statement, and any other relevant materials we make available, before making any decision with respect to the matters to be voted upon at the 2025 Annual Meeting of Shareholders, including the election of directors.
Associated Press
an hour ago
- Associated Press
NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX
HOUSTON, June 24, 2025 /PRNewswire/ -- Nutex Health Inc. ('Nutex Health' or the 'Company') (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced it has been added as a member of the broad-market Russell 3000® Index and the Russell Microcap® Index, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. 'Inclusion in the Russell Indexes is great validation of the Nutex Health business model and will help increase our visibility with long term institutional investors,' stated Jon Bates, Chief Financial Officer of Nutex Health. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the 'Russell Reconstitution' section on the FTSE Russell website. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. About FTSE Russell, an LSEG Business FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering. FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit FTSE Russell. Forward-Looking Statements Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will', 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading 'Risk Factors' in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View original content: SOURCE Nutex Health, Inc.
